Carrier-free nano-prodrugs for minimally invasive cancer therapy
Nanoscale · 2024 · 16 (32) · 15256-15264
DOI: 10.1039/d4nr01763c ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Keita Tanita und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, 980-8577, Japan. koseki@tohoku.ac…. Hauptthemen laut MEDLINE: Prodrugs, Irinotecan, Camptothecin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
SNC4DC, a dimer of SN-38 derivatives, has been synthesized. SNC4DC nanoparticles called nano-prodrugs are internalized into the cell and dissociate, and the active SN-38 is released after reduction of the S–S bond in the presence of GSH occurs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, 980-8577, Japan. koseki@tohoku.ac.jp.
- Research Institute for Electronic Science, Hokkaido University, N20W10, Kita-ku, Sapporo, 001-0020, Japan.
- Graduate School of Engineering, Nagasaki University, 1-14 Bunkyo, Nagasaki, 852-8521, Japan.
- Department of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
- Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
- Department of Medical Oncology, Tohoku University Hospital, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tanita, K., Koseki, Y., Kumar, S., Taemaitree, F., Mizutani, A., Nakatsuji, H., Suzuki, R., Dao, A. T. N., Fujishima, F., Tada, H., Ishida, T., Saijo, K., Ishioka, C., & Kasai, H. (2024). Carrier-free nano-prodrugs for minimally invasive cancer therapy. Nanoscale, 16(32), 15256-15264. https://doi.org/10.1039/d4nr01763c
Vancouver
Tanita K, Koseki Y, Kumar S, Taemaitree F, Mizutani A, Nakatsuji H, et al. Carrier-free nano-prodrugs for minimally invasive cancer therapy. Nanoscale. 2024;16(32):15256-15264. doi:10.1039/d4nr01763c
BibTeX
@article{Tanita2024,
author = {Tanita, Keita and Koseki, Yoshitaka and Kumar, Sanjay and Taemaitree, Farsai and Mizutani, Asuka and Nakatsuji, Hirotaka and Suzuki, Ryuju and Dao, Anh Thi Ngoc and Fujishima, Fumiyoshi and Tada, Hiroshi and Ishida, Takanori and Saijo, Ken and Ishioka, Chikashi and Kasai, Hitoshi},
title = {Carrier-free nano-prodrugs for minimally invasive cancer therapy},
journal = {Nanoscale},
year = {2024},
volume = {16},
number = {32},
pages = {15256--15264},
doi = {10.1039/d4nr01763c}
}
EUVIMED